The Europe Mental Health Screening Market would witness market growth of 12.1% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Mental Health Screening Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $147.8 million by 2031. The UK market is exhibiting a CAGR of 11.1% during (2024 - 2031). Additionally, The France market would experience a CAGR of 12.9% during (2024 - 2031).
Mental health screening is a process used to assess an individual's mental health status and identify potential mental health disorders or issues. It involves using standardized tools or questionnaires to gather information about a person's thoughts, feelings, and behaviors.
Moreover, mental health screening is typically conducted by healthcare professionals, such as psychologists, psychiatrists, or primary care providers, and can be part of routine healthcare visits or specialized mental health assessments.
The demand for mental health screening tools in Europe is rapidly increasing, driven by a pressing need to address the high prevalence of mental health conditions in the region. In 2019, more than 125 million people in the WHO European Region were living with a mental health condition, and many did not receive the necessary care.
Free Valuable Insights: The Global Mental Health Screening Market will Hit USD 2.4 Billion by 2031, at a CAGR of 12.5%
Based on Age Group, the market is segmented into Adults (age 19-64 years), Children & Adolescents (age 0-18 years), and Seniors (age 65 and above). Based on Setting, the market is segmented into Clinical Settings, Educational Institutions & Others, and Workplace/Corporate Programs & Online Platforms. Based on Technology, the market is segmented into Telehealth & Virtual Care Solutions, Self-screening mHealth Apps, AI-based Screening Tools, and Continuous Monitoring Wearable Devices & Others. Based on Screening Method, the market is segmented into Self-reported Questionnaires & Surveys, Clinical Interviews, Observation-based Assessments, and Biomarker Testing. Based on Application, the market is segmented into Physiological Disorders (Depression & Anxiety, Eating Disorder, Post-Traumatic Stress Disorder (PTSD), Bipolar Disorder, and Others), Psychiatric Disorders (Attention Deficit Hyperactivity Disorder (ADHD), Psychotic Disorder, Dissociative Disorder, Obsessive Compulsive Disorder, Schizophrenia, and Others), Cognitive Disorders (Cognitive Impairment, Dementia, and Alzheimer's Disease & Others), and Behavioral Disorders (Self-Harm, Aggression, Sleep Disorder, Social Withdrawal, Dissociative Disorder, Hyperactivity, and Others). Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
By Age Group
By Setting
By Technology
By Screening Method
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 